Vitamin d and prebiotics may prevent pregnancy diabetes
NCT ID NCT06553729
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether taking vitamin D and prebiotics (inulin) during early pregnancy can help control blood sugar in women at high risk for gestational diabetes. 500 pregnant women will receive supplements or placebos from 6-15 weeks of pregnancy. The goal is to see if these simple additions can lower fasting glucose and HbA1c levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vitamin D3 (cholecalciferol) and prebiotics (inulin)
What this could lead to
If it works, this could point toward a simple, safe way to prevent gestational diabetes in high-risk pregnancies.
What could go wrong
This is an early-stage trial with no phase, and the effects may be small or not clinically meaningful. Supplements may not prevent diabetes for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE INTOLERANCE DURING PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Central People's Hospital of Zhanjiang
RECRUITINGZhanjiang, Guangdong, China
Contact Phone: •••-•••-••••
-
Tongji Medical College, Huazhong University of Science and Technology
NOT_YET_RECRUITINGWuhan, Hubei, China
Contact
Contact
Contact Phone: •••-•••-••••